The Effects of Long-Term Treatment with Metrifonate, a Cholinesterase Inhibitor, on Cholinergic Activity, Amyloid Pathology, and Cognitive Function in APP and PS1 Doubly Transgenic Mice
- 1 February 2002
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 173 (2) , 196-204
- https://doi.org/10.1006/exnr.2001.7819
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cholinesterase inhibitors, β-amyloid precursor protein and amyloid β-peptides in Alzheimer's diseaseActa Neurologica Scandinavica, 2000
- ALZHEIMER'S DISEASE: Genetic Studies and Transgenic ModelsAnnual Review of Genetics, 1998
- Intermediate myasthenia syndrome following acute organophosphates poisoning — an analysis of 21 casesHuman & Experimental Toxicology, 1998
- Cholinesterase inhibitors increase secretion of APPs in rat brain cortexNeuroReport, 1995
- Projections from the laterodorsal nucleus of the thalamus to the limbic and visual cortices in the ratJournal of Comparative Neurology, 1992
- Release of Alzheimer Amyloid Precursor Derivatives Stimulated by Activation of Muscarinic Acetylcholine ReceptorsScience, 1992
- Production of the Alzheimer Amyloid β Protein by Normal Proteolytic ProcessingScience, 1992
- Amyloid β-peptide is produced by cultured cells during normal metabolismNature, 1992
- Cleavage of Amyloid β Peptide During Constitutive Processing of Its PrecursorScience, 1990
- A rapid radiochemical method for the determination of choline acetyltransferaseJournal of Neurochemistry, 1975